Jan van de Winkel

Dr. Jan G. J. van de Winkel is an Independent Director at Omega Alpha SPAC, a Chairman-Supervisory Director at Hookipa Biotech AG, a Chairman at HOOKIPA Pharma, Inc., a President & Chief Executive Officer at Genmab A/S, a Professor at University of Utrecht and a Chairman-Supervisory Board at Regenesance BV. He is on the Board of Directors at Omega Alpha SPAC, LEO Pharma A/S and Celdara Medical LLC. Dr. van de Winkel was previously employed as a Member by BTF Pty Ltd., a Member-Supervisory Board by ISA Pharmaceuticals BV, a Vice President by Medarex Europe BV, and a Vice President & Scientific Director by Medarex, Inc. He also served on the board at Forward Pharma A/S. He received his undergraduate degree from the University of Utrecht, a graduate degree from the University of Utrecht, a graduate degree from Radboud University Nijmegen and a doctorate degree from Radboud University Nijmegen.